Topic: Schering-Plough Corporation
The Merck & Co. executive who successfully led the company's legal strategy over the Vioxx recall was named CEO on Tuesday.. Kenneth C. Frazier will succeed Richard T. Clark on Jan. 1. At the time, the move to president of the company ...
At the heart of the Vytorin scandal three years ago was a decision to change the primary endpoint in a key clinical trial, a move that called into question not only the integrity of the so-called Enhance study but the veracity of ...
Merck: Arbitration with Johnson & Johnson over arthritis drugs' revenue to start in weeksDrugmaker Merck & Co. says arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis.The dispute arose ...
Merck and Sanofi-Aventis SA say Raul Kohan will be CEO of their animal health joint venture, which is expected to be the world's largest maker of pet and livestock medicines.Kohan is the president of Merck's animal health business, Intervet/Schering-Plough. The companies said ...
One of Buffet's Banks Wells Fargo CAP IV 7.00% trust preferred shares (NYSE:WSF) are currently yielding 7.3% and trade below par at $23.90. Wells Fargo (NYSE:WFC) recently announced that it shortly plans to return the Federal Government's TARP money taken last year ...
Drugmaker Merck and Co. said Thursday it will close or sell eight research sites and eight manufacturing sites as it looks to save money after buying rival Schering-Plough Corp. last year.Over the next two years, Merck plans to close the following research ...
The week is finally over, and the fluctuations in the market are making many of us jittery. Merck & Co. traces its origins to Friedrich Jacob Merck, who purchased a drug store in Darmstadt, Germany in 1668, and Emanuel Merck, who took ...
Merck: Integration of new Schering-Plough unit is track, new drugs are approaching approvalDrugmaker Merck & Co. says its integration of Schering Plough Corp. is off to a good start, with sales and other operations already combined in the top 20 companies where ...
Merck CEO Clark got $11.9 million in 2009 compensation, down sharply despite major acquisitionMerck & Co.'s chief executive, who oversaw the drug maker's acquisition of Schering-Plough Corp. last fall, received a compensation package valued at $11.9 million in 2009, according to an ...
Two former Schering-Plough executives are taking charge at Bausch & Lomb, whose chairman and CEO is retiring after guiding the company through the aftermath of a devastating contact lens recall.The Rochester, N.Y.-based eye care products maker says that Brent Saunders has been ...
From Around the Web
Video Gallery
-
Nomad Stories Fred Hassan, Schering-Plough Corp
Nomad Stories Fred Hassan, Schering-Plough Corp2008-10-28 -
July 15 Biz Minute
Drugmakers Merck & Co. and Schering-Plough Corp. said today they will ...2009-07-15 -
Robert Spiegel - SVP & CMO Schering-Plough
Prior to his current position, Robert was Senior Vice President ...2009-07-27
